KindlyMD, Inc. NAKA
9.99
0.23
2.36%
as of 25 Sep
- Market cap
- $177.2M
- P/E
- 0.0×
Follow NAKA
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
109.72 | 31.51 | 32.50 | 1.99 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(16.50) | (9.29) | (6.04) | (24.29) | |
P/B ratio |
0.46 | 0.14 | 0.38 | 0.33 | |
Price to Tangible BV |
0.46 | 0.14 | 0.82 | 0.64 | |
EV/Sales |
97.51 | 22.07 | 24.35 | 1.51 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(11.46) | (2.09) | (2.29) | (1.27) | |
EV/FCF |
(0.28) | (0.07) | (0.14) | (0.09) | |
Quick Ratio |
0.11 | 0.10 | 0.14 | 0.11 | |
Current Ratio |
0.13 | 1.04 | 0.25 | 0.15 | |
Net Debt/EBITDA |
2.32 | 0.11 | 0.28 | 0.46 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.01 | 0.01 | 0.01 | 0.18 | |
Operating CF/Net income |
0.15 | (0.20) | 0.10 | 0.02 | |
Capex/Depreciation |
(798.36) | (6.08) | 14.97 | (0.02) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2,777.25% | 1,227.65% | 639.69% | 39.83% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.31 | 0.27 | |
Share Based Compensation of Revenue |
554.53% | 24.17% | 60.01% | 6.22% | |
Graham Net Nets |
(0.86) | 0.11 | (1.35) | (2.01) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(103.74%) | (247.86%) | (488.69%) | (907.59%) | |
Free Cash Flow Yield |
(322.69%) | (1,028.19%) | (532.29%) | (870.81%) | |
Revenue per Share |
0.08 | 0.17 | 0.17 | 1.79 | |
Operating CF per Share |
(2.59) | (1.51) | (1.46) | (0.16) | |
Capex per Share |
(126.34) | (2.75) | 1.05 | (0.11) | |
Free Cash Flow per Share |
(128.94) | (4.26) | (0.41) | (0.27) | |
Cash per Share |
4.76 | 4.21 | 2.22 | 0.95 | |
Shareholders Equity per Share |
94.06 | 102.75 | 23.07 | 11.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
94.06 | 102.75 | 23.07 | 11.82 | |
Free Cash Flow |
(654.65) | (21.34) | (6.59) | (5.35) | |
Working Capital |
(187.41) | 7.83 | (188.28) | (152.02) | |
Capital Expenditures |
(641.48) | (13.78) | 16.69 | (2.10) | |
Net Current Asset Value |
(187.81) | 7.47 | (190.27) | (158.65) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
1,652.45 | 16.15 | (6.23) | 0.06 | |
Net Profit Margin |
(22,162.75%) | 4,367.47% | (8,916.21%) | (370.79%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
3.14 | 2.68 | 6.73 | 5.67 | |
Average Assets |
348.37 | 367.14 | 311.66 | 216.20 | |
Average Common Equity |
240.52 | 258.41 | 184.30 | 122.69 |
Columns are period end dates